Rockwell Med (RMTI) has issued an announcement.
Rockwell Medical, Inc. has amended its asset purchase agreement with Evoqua Water Technologies, adjusting payment terms and reducing the initial deferred payment after accounting for certain expenses. Additionally, CEO Mark Strobeck reaffirmed the company’s gross margin target for 2024 in an interview, rectifying an earlier misstatement. The company emphasizes the non-GAAP measure of adjusted gross margin to reflect its core operations, excluding a one-off revenue item. However, it also acknowledges that non-GAAP measures have limitations and should be viewed alongside GAAP results. Forward-looking statements regarding financial projections are made with the usual caveats of potential risks and uncertainties that could affect actual outcomes.
For detailed information about RMTI stock, go to TipRanks’ Stock Analysis page.
